IAG hopeful about transatlantic restart, BofA says

by | Mar 26, 2021

IAG thinks successful vaccine programmes in the US and UK bode well for transatlantic travel restarting, Bank of America said.
British Airways owner IAG is flying 20% of capacity and doesn’t expect any meaningful increase before 17 May when UK travel is scheduled to restart, IAG officials told BofA.

“IAG views progress in vaccination rollout in the UK and US positively for transatlantic travel,” BofA said. “A potential UK-US reopening in May would be very positive and ahead of expectations. All IAG airlines can ramp up to >70% capacity at short notice.”

BofA said it expected a travel recovery for airlines this summer despite recent headlines about tougher restrictions.

Travel and leisure companies are cautiously optimistic about rising demand, the bank said, keeping IAG and easyJet as its top airline picks. After early problems the EU’s vaccine programme will pick up in the second quarter, allowing easing of travel restrictions, BofA said.

IAG’s summer bookings have increased since the UK government’s travel announcement although most bookings are for last-minute essential travel. Spanish and Latin American routes are the strongest.

The company is ready to enter markets as rivals pull out or cut capacity, investor relations chief Andrew Light told BofA. The company is also comfortable with its 10.3bn of liquidity.

EasyJet bookings have surged when travel restrictions have loosened and is seeing interest in its 2022 programme earlier than usual, chief operating officer Peter Bellew told BofA. The company is not feeling fare pressure from competitors and is clamping down on costs, Bellew said.

BofA kept its ‘buy’ ratings on both airlines. It left IAG’s price target at 250p and raised easyJet’s target to £11.50 from £11.

IAG shares rose 1.3% to 196.15p at 14:49 GMT and easyJet shares rose 2.6% to 966.14p.

Related articles

RBC Capital cuts Rentokil price target

RBC Capital cuts Rentokil price target

(Sharecast News) - RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded forecasts for forex and a greater back-end loading of TMX synergies, but said it believes the long-term story remains intact. The bank said...

Trending stories

Join our mailing list

Subscribe to our mailing list to receive regular updates!

x